Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Changes in 24-Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy.

Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder RE, Kirtane AJ, Böhm M, Hettrick DA, Townsend RR, Tsioufis KP.

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11913081. doi: 10.1161/HYPERTENSIONAHA.119.13081. [Epub ahead of print] No abstract available.

PMID:
31256723
2.

Evidence of neurodegeneration in individuals with only mildly elevated blood pressure.

Jung S, Bosch A, Kohler N, Ott C, Kannenkeril D, Dienemann T, Harazny JM, Michelson G, Schmieder RE.

J Hypertens. 2019 Jun 24. doi: 10.1097/HJH.0000000000002164. [Epub ahead of print]

PMID:
31246897
3.

Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.

Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD.

JACC Cardiovasc Interv. 2019 Jun 24;12(12):1095-1105. doi: 10.1016/j.jcin.2019.02.050. Review.

PMID:
31221299
4.

Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review.

Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, DiBona GF, Everett TH 4th, Grassi G, Katholi RE, Knuepfer MM, Kopp UC, Lefer DJ, Lohmeier TE, May CN, Mahfoud F, Paton JFR, Schmieder RE, Pellegrino PR, Sharabi Y, Schlaich MP.

J Am Coll Cardiol. 2019 Jun 18;73(23):3006-3017. doi: 10.1016/j.jacc.2019.04.015. Review.

PMID:
31196459
5.

Tissue sodium content in patients with type 2 diabetes mellitus.

Kannenkeril D, Karg MV, Bosch A, Ott C, Linz P, Nagel AM, Uder M, Schmieder RE.

J Diabetes Complications. 2019 Jul;33(7):485-489. doi: 10.1016/j.jdiacomp.2019.04.006. Epub 2019 Apr 16.

PMID:
31101486
6.

Patient preference for therapies in hypertension: a cross-sectional survey of German patients.

Schmieder RE, Högerl K, Jung S, Bramlage P, Veelken R, Ott C.

Clin Res Cardiol. 2019 Apr 2. doi: 10.1007/s00392-019-01468-0. [Epub ahead of print]

PMID:
30941492
7.

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial.

Bosch A, Ott C, Jung S, Striepe K, Karg MV, Kannenkeril D, Dienemann T, Schmieder RE.

Cardiovasc Diabetol. 2019 Mar 29;18(1):44. doi: 10.1186/s12933-019-0839-8.

8.

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149.

PMID:
30919899
9.

Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, Bloch MJ, Basile J, Wang Y, Saxena M, Lurz P, Rader F, Sayer J, Fisher NDL, Fouassier D, Barman NC, Reeve-Stoffer H, McClure C, Kirtane AJ; RADIANCE-HTN Investigators.

Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040451. [Epub ahead of print]

PMID:
30880441
10.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

Kardiol Pol. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. Polish. No abstract available.

11.

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience.

Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE.

Clin Exp Nephrol. 2019 Jun;23(6):749-755. doi: 10.1007/s10157-019-01697-7. Epub 2019 Feb 19.

PMID:
30783914
12.

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder RE, Eckardt KU.

Kidney Int Rep. 2018 Oct 11;4(2):267-274. doi: 10.1016/j.ekir.2018.10.004. eCollection 2019 Feb.

13.

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Mahfoud F, Böhm M, Bongarth CM, Bosch R, Schmieder RE, Schunkert H, Stellbrink C, Trenkwalder P, Vonend O, Weil J, Kreutz R.

Internist (Berl). 2019 Apr;60(4):424-430. doi: 10.1007/s00108-019-0576-9. Review. German.

PMID:
30770942
14.

Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.

Ott C, Bosch A, Winzer N, Friedrich S, Schinzel R, Tegtmeier F, Schmieder RE.

Br J Clin Pharmacol. 2019 May;85(5):900-907. doi: 10.1111/bcp.13870. Epub 2019 Feb 28.

PMID:
30666700
15.

[European guidelines for the management of arterial hypertension 2018-what has changed?]

Jung S, Schmieder RE.

Internist (Berl). 2019 Feb;60(2):202-208. doi: 10.1007/s00108-018-0552-9. Review. German.

PMID:
30649580
16.

Reply.

Schmieder RE, Mahfoud F.

J Hypertens. 2019 Feb;37(2):454. doi: 10.1097/HJH.0000000000001993. No abstract available.

PMID:
30640879
17.

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S.

Eur Heart J. 2018 Dec 24. doi: 10.1093/eurheartj/ehy808. [Epub ahead of print]

PMID:
30590564
18.

Secretory Capacity of Pancreatic Beta-Cells Is Enhanced 6 Months After Renal Denervation in Hypertensive Patients.

Ott C, Schmid A, Mahfoud F, Akarca E, Kistner I, Ditting T, Veelken R, Böhm M, Uder M, Schmieder RE.

J Am Coll Cardiol. 2018 Dec 25;72(25):3372-3374. doi: 10.1016/j.jacc.2018.09.075. No abstract available.

PMID:
30573036
19.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I.

G Ital Cardiol (Rome). 2018 Nov;19(11):3-73. doi: 10.1714/3026.30245. Italian. No abstract available.

PMID:
30520455
20.

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP.

Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.

PMID:
30354716
21.

Interpretation of noninvasive retinal microvascular studies: the individual source of the automatic full field imaging analysis program has to be taken into account.

Harazny JM, Schmieder RE.

J Hypertens. 2018 Nov;36(11):2277. doi: 10.1097/HJH.0000000000001881. No abstract available.

PMID:
30256326
22.

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; Authors/Task Force Members:.

J Hypertens. 2018 Oct;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940.

PMID:
30234752
23.

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes.

Kannenkeril D, Bosch A, Harazny J, Karg M, Jung S, Ott C, Schmieder RE.

Cardiovasc Diabetol. 2018 Sep 19;17(1):128. doi: 10.1186/s12933-018-0770-4.

24.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available.

PMID:
30165516
25.

Application of a central iliac arteriovenous coupler device in severe treatment-resistant hypertension: a 3.5-year follow-up.

Jung S, Ott C, Karg MV, Bosch A, Schmid M, Schlundt C, Achenbach S, Schmieder RE.

J Hypertens. 2018 Dec;36(12):2471-2477. doi: 10.1097/HJH.0000000000001873.

PMID:
30113527
26.

European Society of Hypertension position paper on renal denervation 2018.

Schmieder RE, Mahfoud F, Azizi M, Pathak A, Dimitriadis K, Kroon AA, Ott C, Scalise F, Mancia G, Tsioufis C; Members of the ESH Working Group on Interventional Treatment of Hypertension.

J Hypertens. 2018 Oct;36(10):2042-2048. doi: 10.1097/HJH.0000000000001858.

PMID:
30015759
27.

Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success.

Saxena M, Shour T, Shah M, Wolff CB, Julu POO, Kapil V, Collier DJ, Ng FL, Gupta A, Balawon A, Pheby J, Zak A, Rull G, O'Brien B, Schmieder RE, Lobo MD.

J Am Heart Assoc. 2018 Jun 12;7(12). pii: e009151. doi: 10.1161/JAHA.118.009151.

28.

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators.

Lancet. 2018 Jun 9;391(10137):2335-2345. doi: 10.1016/S0140-6736(18)31082-1. Epub 2018 May 23. Erratum in: Lancet. 2018 Sep 8;392(10150):820.

PMID:
29803590
29.

Correction to: Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Apr 9;20(3):27. doi: 10.1007/s11906-018-0844-4.

PMID:
29629502
30.

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP.

Microvasc Res. 2018 Jul;118:121-127. doi: 10.1016/j.mvr.2018.03.008. Epub 2018 Mar 17.

PMID:
29559377
31.

Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.

Bertog SC, Sobotka NA, Sobotka PA, Lobo MD, Sievert K, Vaskelyte L, Sievert H, Schmieder RE.

Curr Hypertens Rep. 2018 Mar 19;20(3):18. doi: 10.1007/s11906-018-0816-8. Review. Erratum in: Curr Hypertens Rep. 2018 Apr 9;20(3):27.

PMID:
29556742
32.

Renal denervation improves 24-hour central and peripheral blood pressures, arterial stiffness, and peripheral resistance.

Ott C, Franzen KF, Graf T, Weil J, Schmieder RE, Reppel M, Mortensen K.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):366-372. doi: 10.1111/jch.13193. Epub 2018 Jan 25.

33.

Individualised treatment targets in patients with type-2 diabetes and hypertension.

Schmieder RE, Tschöpe D, Koch C, Ouarrak T, Gitt AK; DIALOGUE study group.

Cardiovasc Diabetol. 2018 Jan 22;17(1):18. doi: 10.1186/s12933-018-0661-8.

34.

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.

Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE.

Cardiovasc Diabetol. 2018 Jan 4;17(1):5. doi: 10.1186/s12933-017-0654-z.

35.

Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Bosch AJ, Harazny JM, Kistner I, Friedrich S, Wojtkiewicz J, Schmieder RE.

BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x.

36.

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.

Mauri L, Kario K, Basile J, Daemen J, Davies J, Kirtane AJ, Mahfoud F, Schmieder RE, Weber M, Nanto S, Azizi M.

Am Heart J. 2018 Jan;195:115-129. doi: 10.1016/j.ahj.2017.09.006. Epub 2017 Sep 12.

PMID:
29224639
37.

Central arteriovenous anastomosis to treat resistant hypertension.

Kapil V, Sobotka PA, Lobo MD, Schmieder RE.

Curr Opin Nephrol Hypertens. 2018 Jan;27(1):8-15. doi: 10.1097/MNH.0000000000000379. Review.

PMID:
29084002
38.

Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial.

Lobo MD, Ott C, Sobotka PA, Saxena M, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Schmieder RE.

Hypertension. 2017 Dec;70(6):1099-1105. doi: 10.1161/HYPERTENSIONAHA.117.10142. Epub 2017 Oct 23.

PMID:
29061728
39.

Retinal vascular resistance in arterial hypertension.

Kannenkeril D, Harazny JM, Bosch A, Ott C, Michelson G, Schmieder RE, Friedrich S.

Blood Press. 2018 Apr;27(2):82-87. doi: 10.1080/08037051.2017.1393311. Epub 2017 Oct 23.

PMID:
29057671
40.

Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV.

Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Ormiston J, Saxena M, Sharp ASP, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo MD.

J Hypertens. 2018 Mar;36(3):680-689. doi: 10.1097/HJH.0000000000001584.

PMID:
29035942
41.

The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.

Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Hrabak-Paar M, Heye T, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J.

Eur Heart J. 2017 Nov 21;38(44):3308-3317. doi: 10.1093/eurheartj/ehx525.

PMID:
29029087
42.

Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients.

Mancia G, Schumacher H, Böhm M, Redon J, Schmieder RE, Verdecchia P, Sleight P, Teo K, Yusuf S.

Hypertension. 2017 Nov;70(5):938-948. doi: 10.1161/HYPERTENSIONAHA.117.09714. Epub 2017 Oct 3.

PMID:
28974567
43.

Reply.

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, de Leeuw PW, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.

J Hypertens. 2017 Nov;35(11):2327-2328. doi: 10.1097/HJH.0000000000001526. No abstract available.

44.

Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus.

Striepe K, Jumar A, Ott C, Karg MV, Schneider MP, Kannenkeril D, Schmieder RE.

Circulation. 2017 Sep 19;136(12):1167-1169. doi: 10.1161/CIRCULATIONAHA.117.029529. No abstract available.

PMID:
28923906
45.

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.

Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M; SPYRAL HTN-OFF MED trial investigators*.

Lancet. 2017 Nov 11;390(10108):2160-2170. doi: 10.1016/S0140-6736(17)32281-X. Epub 2017 Aug 28.

PMID:
28859944
46.

Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension.

Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE.

Clin Res Cardiol. 2018 Jan;107(1):42-48. doi: 10.1007/s00392-017-1156-4. Epub 2017 Aug 28.

PMID:
28845508
47.

Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses.

Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black JA, Bos WJ, Chambers JB, Chen CH, Cheng HM, Cremer A, Davies JE, Dwyer N, Gould BA, Hughes AD, Lacy PS, Laugesen E, Liang F, Melamed R, Muecke S, Ohte N, Okada S, Omboni S, Ott C, Peng X, Pereira T, Pucci G, Rajani R, Roberts-Thomson P, Rossen NB, Sueta D, Sinha MD, Schmieder RE, Smulyan H, Srikanth VK, Stewart R, Stouffer GA, Takazawa K, Wang J, Westerhof BE, Weber F, Weber T, Williams B, Yamada H, Yamamoto E, Sharman JE.

J Am Coll Cardiol. 2017 Aug 1;70(5):572-586. doi: 10.1016/j.jacc.2017.05.064. Review.

48.

Expertise: no longer a sine qua non for guideline authors?

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B, de Leeuw PW.

J Hypertens. 2017 Aug;35(8):1564-1566. doi: 10.1097/HJH.0000000000001435.

49.

Expertise: No Longer a Sine Qua Non for Guideline Authors?

Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, Grodzicki T, Kario K, Kjeldsen SE, Kostis JB, Laurent S, Leenen FH, Lund-Johansen P, Mancia G, Narkiewicz K, Papademetriou V, Parati G, Poulter N, Redon J, Rimoldi SF, Ruilope LM, Schiffrin EL, Schmieder RE, Schwartz AB, Sever P, Sowers JR, Staessen JA, Wang J, Weber M, Williams B.

Hypertension. 2017 Aug;70(2):235-237. doi: 10.1161/HYPERTENSIONAHA.117.09470. Epub 2017 Jun 26. No abstract available.

50.

[Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs)].

Freudenmann RW, Freudenmann N, Zurowski B, Schönfeldt-Lecuona C, Maier L, Schmieder RE, Lange-Asschenfeldt C, Gahr M.

Dtsch Med Wochenschr. 2017 Aug;142(16):e100-e107. doi: 10.1055/s-0043-111739. Epub 2017 Jun 23. German.

PMID:
28645134

Supplemental Content

Loading ...
Support Center